Page 1370 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1370

CHAPTER 99: Electrolyte Disorders in Critical Care   943


                    Removal of cytokines in the setting of sepsis and AKI via hemadsorp-    • Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical
                    tion (coupled with hemofiltration) has been demonstrated as feasible     trial of continuous versus intermittent dialysis for acute renal fail-
                    and effective at improving hemodynamics and survival in animal     ure. Kidney Int. 2001;60:1154-1163.
                    studies. 93,94  Similarly, high cutoff hemofiltration (HCO) has demonstrated
                    effectiveness in clearance of cytokines and improving hemodynamics     • Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy
                    in sepsis and AKI in both animal and human studies. However, more   with high cut-off hemofilters: impact of convection and diffu-
                    effective removal of cytokines was complicated by removal of albumin as   sion on cytokine clearances and protein status. Am J Kidney Dis.
                    well, questioning the relative risk versus benefit of HCO and highlight-  2004;43:444-453.
                    ing the need for future investigation. 95,96,97           • Parienti J, Thirion M, Megarbane B, et al. Femoral vs jugular
                     The RAD represents the most advanced form of RRT that truly   venous catheterization and risk of nosocomial events in adults
                    attempts to mimic renal “replacement.” Nonautologous cultured tubular   requiring  acute  renal  replacement therapy:  a  randomized  con-
                    cells grown along the inner surface of hollow fibers are placed in series   trolled trial. JAMA. 2008;299:2413-2422.
                    with a conventional RRT circuit. The ultrafiltrate is pumped through     • The RENAL Replacement Study Investigators. Intensity of contin-
                    the RAD allowing the renal cells to emulate their native functions.   uous renal replacement therapy in critically-ill patients. N Engl J
                    Animal data suggested its potential benefit and human studies have   Med. 2009;361:1627-1638.
                    demonstrated not only safety, but also preliminary efficacy. Specifically,     • Trotman RL, Williamson JC, Shoemaker M, Salzer WL. Antibiotic
                    a phase II, randomized controlled trial of CRRT with the RAD versus   dosing in critically ill adult patients receiving continuous renal
                    conventional CRRT alone demonstrated improved survival and renal   replacement therapy. Clin Infect Dis. 2005;41:1159-1166.
                    recovery. Forty patients  were assigned to CRRT plus the RAD and
                    18 patients were assigned to conventional CRRT. Renal recovery      • Uchino  S,  Kellum  JA,  Bellomo  R, et al. Acute renal  failure  in
                    and overall 28- and 180-day survival was better in the RAD group   critically ill patients: a multinational, multicenter study.  JAMA.
                    compared with the conventional CRRT group.  However, a subsequent   2005;294(7):813-818.
                                                     98
                    phase IIb trial was unsuccessful,  and development efforts continue.    • Udy AA, Baptista JP, Lim NL, et al. Augmented renal clearance
                                           99
                                                                             in the ICU: results of a multicenter observational study of renal
                    CONCLUSION                                               function in critically ill patients with normal plasma creatinine
                                                                             concentrations. Crit Care Med. 2014;42(3):520-527.
                    We have made significant progress in making RRT more accessible to     • VA/NIH Acute Renal Failure Trial Network. Intensity of renal
                    the critically ill. Increased overall collaboration between intensivists and   support in critically ill patients with acute kidney injury. N Engl J
                    nephrologists has increased access to RRT and increased the potential   Med. 2008;359:7-20.
                    for better outcomes in critically ill individuals with AKI requiring RRT.
                    Large, coordinated investigative efforts have allowed the critical care     • Vinsonneau C, Camus C, Combes A, et al. Continuous venovenous
                                                                             hemodiafiltration versus intermittent hemodialysis for acute renal
                    nephrology community to reach some important conclusions: (1) there
                    is a minimal, acceptable dose of RRT in AKI, but more intense CRRT   failure in patients with multiple-organ dyfunction syndrome: a
                                                                             multicenter randomized trial. Lancet. 2006;368:379-385.
                    or daily IHD does not improve outcomes for all patients and (2) CRRT
                    is not superior to IHD in many AKI cases, and IHD can be safely      • Wald R, Shariff SZ, Adhikari NK, et al. The association between
                    performed on many critically ill patients with multiorgan system failure.   renal  replacement  therapy  modality  and  long-term  outcomes
                    Nevertheless, we have significant room for improving our understand-  among critically ill adults with acute kidney injury: a retrospective
                    ing of the application of RRT to critically ill patients. Determining the   cohort study. Crit Care Med. 2014;42(4):868-877.
                    optimal time point to initiate RRT and the best approach to adjusting
                    the dose of RRT to the underlying clinical environment remain two impor-
                    tant areas that require further investigation. Finally, we need to move  REFERENCES
                    this field to the point where we are truly providing renal “replacement,”
                    accounting for innovative filter and circuit characteristics as well as   Complete references available online at www.mhprofessional.com/hall
                    providing optimal supportive care including nutritional support and
                    appropriate medication adjustment. Once all of these components are
                    in place, patients may receive the maximal benefit of extracorporeal    CHAPTER  Electrolyte Disorders
                    support with fewer complications.                                 in Critical Care
                                                                            99
                                                                                      Caitriona McEvoy
                                                                                      Patrick T. Murray
                     KEY REFERENCES
                        • Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized
                       controlled trial of intermittent with continuous dialysis with ARF.   KEY POINTS
                       Am J Kidney Dis. 2004;44:1000-1007.                    • Measurement of electrolyte-free water clearance is extremely use-
                        • Bouchard J, Soroko SB, Chertown GM, et al. Fluid accumulation,   ful in understanding the pathophysiology of hyponatremia and
                       survival and recovery of kidney function in critically ill patients   hypernatremia.
                       with acute kidney injury. Kidney Int. 2009;76:422-427.    • Treatment of hyponatremia should be guided by the degree of symp-
                        • Kutsogiannis DJ, Gibney RTN, Stollery D, Gao J. Regional citrate   tomatology, rather than the magnitude of the hyponatremia per se.
                       versus systemic heparin anticoagulation for continuous renal     • Hyperkalemia should be treated emergently if typical electrocar-
                       replacement in critically ill patients. Kidney Int. 2005;67:2361-2367.  diographic (ECG) changes are present; hence, ECG monitoring is
                        • Lins RL, Elseviers MM, Van der Niepen P, et al. Intermittent   indispensable in this setting
                       versus continuous renal replacement therapy for acute kidney     • Hypocalcemia need only be treated urgently if it is symptomatic.
                       injury patients admitted to the intensive care unit: results
                       of a randomized clinical trial.  Nephrol Dial Transplant.       • Severe hyperphosphatemia is seen in the setting of renal failure
                       2009;24:512-518.                                      and/or massive cell lysis.








            section08.indd   943                                                                                       1/14/2015   8:28:02 AM
   1365   1366   1367   1368   1369   1370   1371   1372   1373   1374   1375